IL96782A - Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs - Google Patents

Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs

Info

Publication number
IL96782A
IL96782A IL9678290A IL9678290A IL96782A IL 96782 A IL96782 A IL 96782A IL 9678290 A IL9678290 A IL 9678290A IL 9678290 A IL9678290 A IL 9678290A IL 96782 A IL96782 A IL 96782A
Authority
IL
Israel
Prior art keywords
compound
formula
afford
amino
defined above
Prior art date
Application number
IL9678290A
Other languages
English (en)
Hebrew (he)
Other versions
IL96782A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL96782A0 publication Critical patent/IL96782A0/xx
Publication of IL96782A publication Critical patent/IL96782A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL9678290A 1989-12-27 1990-12-25 Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs IL96782A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45761089A 1989-12-27 1989-12-27
US59449790A 1990-10-09 1990-10-09

Publications (2)

Publication Number Publication Date
IL96782A0 IL96782A0 (en) 1991-09-16
IL96782A true IL96782A (en) 1994-10-21

Family

ID=27038667

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9678290A IL96782A (en) 1989-12-27 1990-12-25 Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs

Country Status (13)

Country Link
EP (1) EP0435222A3 (fr)
JP (1) JPH085861B2 (fr)
KR (1) KR100190783B1 (fr)
AU (1) AU631953B2 (fr)
CA (1) CA2032973A1 (fr)
CZ (1) CZ282665B6 (fr)
HU (1) HUT56347A (fr)
IE (1) IE904679A1 (fr)
IL (1) IL96782A (fr)
NO (1) NO905543L (fr)
PL (1) PL288420A1 (fr)
PT (1) PT96363A (fr)
YU (1) YU244990A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902312A (en) * 1989-01-30 1990-02-20 Allied-Signal Inc. Carbon molecular sieves for purification of chlorofluorocarbons
JPH06507178A (ja) * 1991-09-24 1994-08-11 ファイザー　インク レチノイド類、並びに皮膚疾患及び白血病の治療におけるそれらの使用法
US6008361A (en) * 1996-04-09 1999-12-28 Pfizer Inc. Substituted pyridines
US6031105A (en) * 1996-04-09 2000-02-29 Pfizer Inc Substituted pyridines
PT842924E (pt) * 1996-11-14 2003-12-31 Pfizer Intermediarios de piridina uteis na sintese de agonistas de receptores beta-adrenergicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6604123A (fr) * 1965-05-28 1966-11-29
DE2617101A1 (de) * 1976-04-17 1977-11-17 Thomae Gmbh Dr K Neue naphthyridine
DE3641698A1 (de) * 1986-04-29 1987-11-05 Basf Ag Verfahren zur herstellung von heteroaromatischen aminoaldehyden
US5051430A (en) * 1990-09-10 1991-09-24 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1H-indazol-3-yl)-4-pyridinamines

Also Published As

Publication number Publication date
NO905543D0 (no) 1990-12-21
HUT56347A (en) 1991-08-28
AU631953B2 (en) 1992-12-10
KR910011792A (ko) 1991-08-07
IE904679A1 (en) 1991-07-17
PL288420A1 (en) 1992-06-15
EP0435222A3 (en) 1991-12-11
JPH05345762A (ja) 1993-12-27
CZ282665B6 (cs) 1997-08-13
IL96782A0 (en) 1991-09-16
KR100190783B1 (ko) 1999-06-01
JPH085861B2 (ja) 1996-01-24
YU244990A (sh) 1993-05-28
HU908403D0 (en) 1991-07-29
PT96363A (pt) 1991-09-30
EP0435222A2 (fr) 1991-07-03
CZ658590A3 (en) 1997-05-14
CA2032973A1 (fr) 1991-06-28
AU6840990A (en) 1991-07-04
NO905543L (no) 1991-06-28

Similar Documents

Publication Publication Date Title
SK70899A3 (en) 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
US5059602A (en) 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
EP0477903B1 (fr) Amino-4-pyridinols-3 substitués, procédé pour leur préparation et leur utilisation comme médicaments
IL96782A (en) Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs
US5095019A (en) 4-substituted dihydropyrido(4,3-D)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
US5414004A (en) Neurotransmitter releasers useful for cognition enhancement
IE902330L (en) Naphthylamino-and napththyloxy-pyridinamines
US5055476A (en) 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
EP0094422B1 (fr) Pyridines substituees
EP0475352B1 (fr) (1H-Indazolyl-3)-3 pyridineamines-4, procédé et produits intermédiaires pour leur préparation et leur application comme médicaments
US5039811A (en) Preparation of N-(pyridinyl)-1H-indol-1-amines
US5166163A (en) 3-(1H-indazol-3-yl)-4-pyridinamines
US5532247A (en) Neurotransmitter releasers useful for cognition enhancement
MXPA99007937A (en) Quinoxalinediones

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
MM9K Patent not in force due to non-payment of renewal fees